Peficitinib is a selective Janus kinase (JAK) inhibitor used for the treatment of rheumatoid arthritis in patients who have shown an inadequate response to existing disease-modifying antirheumatic drugs.… Read more
Peficitinib is a selective Janus kinase (JAK) inhibitor used for the treatment of rheumatoid arthritis in patients who have shown an inadequate response to existing disease-modifying antirheumatic drugs. This category provides comprehensive analytical tools for drug development and regulatory compliance, including high-quality reference standards of the Peficitinib active pharmaceutical ingredient, its identified pharmacopeial and non-pharmacopeial impurities, and various metabolic derivatives. Pharmaceutical laboratories utilize these materials for rigorous impurity profiling, method validation, and routine quality control to ensure therapeutic consistency. Additionally, the collection includes stable isotope-labelled compounds, such as deuterated and 15N-labelled variants, which are essential as internal standards for accurate quantification in complex bioanalytical assays and mass spectrometry-based studies. These compounds support the precise monitoring of drug stability and metabolic pathways throughout the research and manufacturing lifecycle.